Global Fecal Occult Testing Market 2019-2023
SKU ID : TNV-14439842 | Publishing Date : 08-Jul-2019 | No. of pages : 122
Detailed TOC of Global Fecal Occult Testing Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY END-USER
Market segmentation by end-user
Comparison by end-user
Hospitals - Market size and forecast 2018-2023
Physicians' office laboratories - Market size and forecast 2018-2023
Clinical diagnostic laboratories - Market size and forecast 2018-2023
Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Growing demand for POC testing
Technological advances in fecal occult tests for CRC screening
Availability of a broad range of CRC screening products
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Abbott Laboratories
bioMérieux SA
Danaher Corp.
Eiken Chemical Co. Ltd.
Quidel Corp.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%)
Exhibit 21: Physicians' office laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Physicians' office laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 23: Clinical diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Clinical diagnostic laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott Laboratories - Vendor overview
Exhibit 46: Abbott Laboratories - Business segments
Exhibit 47: Abbott Laboratories - Organizational developments
Exhibit 48: Abbott Laboratories - Geographic focus
Exhibit 49: Abbott Laboratories - Segment focus
Exhibit 50: Abbott Laboratories - Key offerings
Exhibit 51: bioMérieux SA - Vendor overview
Exhibit 52: bioMérieux SA - Business segments
Exhibit 53: bioMérieux SA - Organizational developments
Exhibit 54: bioMérieux SA - Geographic focus
Exhibit 55: bioMérieux SA - Key offerings
Exhibit 56: Danaher Corp. - Vendor overview
Exhibit 57: Danaher Corp. - Business segments
Exhibit 58: Danaher Corp. - Organizational developments
Exhibit 59: Danaher Corp. - Geographic focus
Exhibit 60: Danaher Corp. - Segment focus
Exhibit 61: Danaher Corp. - Key offerings
Exhibit 62: Eiken Chemical Co. Ltd. - Vendor overview
Exhibit 63: Eiken Chemical Co. Ltd. - Business segments
Exhibit 64: Eiken Chemical Co. Ltd. - Organizational developments
Exhibit 65: Eiken Chemical Co. Ltd. - Geographic focus
Exhibit 66: Eiken Chemical Co. Ltd. - Key offerings
Exhibit 67: Quidel Corp. - Vendor overview
Exhibit 68: Quidel Corp. - Business segments
Exhibit 69: Quidel Corp. - Organizational developments
Exhibit 70: Quidel Corp. - Geographic focus
Exhibit 71: Quidel Corp. - Key offerings
Exhibit 72: Validation techniques employed for market sizing
Exhibit 73: Definition of market positioning of vendors